View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 16, 2022

Innovaderm extends collaboration for TransPerfect’s Trial Interactive

Trial Interactive boosts compliance, speed and quality across site detection, selection and activation.

TransPerfect Life Sciences and the contract research organisation (CRO) Innovaderm have expanded their partnership to scale the deployment of the former’s Trial Interactive to facilitate and streamline remote clinical operations.

Free Report
img

Spot leading innovative companies with GlobalData’s Innovation Scorecard

Innovation remains a necessity in a disruptive ecosystem, as continuous innovation allows companies to adapt, evolve, and grow through disruption. Using our in-house alternative datasets, we are excited to launch GlobalData’s Innovation Scorecard. This scorecard will allow clients to rank 3,500+ companies on their innovation activity, impact, and disruptive potential across geography, sector, and theme. The scorecard provides a data-driven framework to rank leading companies on the potential of their intellectual property (IP) portfolio. GlobalData’s Innovation Scorecard focuses not only on the activity of innovation in the organization but also on its impact and disruptive potential using the 3I framework: Intensity, Impact, and Ingenuity. The tool helps clients to identify the most innovative companies that are disruptive leaders and challengers and can create alpha for their portfolio using the insights driven by 19+ high-value KPIs. Download our report to find out more about this innovative tool. Key findings derived from this tool include:
  • Alphabet, Tencent, and Qualcomm are the top three innovative companies in the last 10 years
  • The scorecard finds Technology & Communications and Pharma & Healthcare as the two main sectors driving innovation
  • Loreal placed as ‘Disruptive Leader’ in the Consumer sector, while Revlon has been identified as a traditional laggard
  • Companies such as Etsy and H&M are challenging retail ‘Disruptive Leaders’ Amazon and Walmart
by GlobalData
Enter your details here to receive your free Report.

Innovaderm used Trial Interactive remote monitoring rooms to advance research and aid partners in discovering new treatments during the Covid-19 pandemic. 

The company allowed customers to use Trial Interactive’s Study Document Collaboration solution by integrating tailored remote monitoring rooms into its service offering, thereby facilitating successful execution of trials remotely.

Innovaderm and TransPerfect’s collaboration started with language translation services years ago.

Subsequently, Innovaderm deployed Trial Interactive’s eTMF to replace its paper-based method for document management of clinical trials.

With Innovaderm further streamlining its clinical research strategy, the organisation’s manual process to supply and collect crucial documents from sites was substituted by TI Study Start-Up.

This offered a clear pathway to activate sites and lowered timelines to commence new trials.

The platform offers document and trial management solutions that are user-friendly, aiding pharmaceutical, biotechnology companies and CROs optimise product development life cycles. 

Trial Interactive is a connected eClinical experience that boosts compliance, speed and quality across site detection, selection and activation.

Furthermore, in a secure 21 CFR Part 11-compliant environment, it delivers quick-to-implement solutions.

Innovaderm Clinical Operations director Isabel Dorion said: “Trial Interactive worked with us to ensure our remote monitoring room configuration met our key requirements so we could conduct our studies without interruptions, delays, or significant changes. 

“As we’ve faced unexpected shifts in the way we run and monitor studies, Trial Interactive has been key to enabling us to perform remote monitoring visits.”

In December 2019, TransPerfect unveiled the 10.0 version of its Trial Interactive e-clinical platform (TI10).

Related Companies

Free Report
img

Spot leading innovative companies with GlobalData’s Innovation Scorecard

Innovation remains a necessity in a disruptive ecosystem, as continuous innovation allows companies to adapt, evolve, and grow through disruption. Using our in-house alternative datasets, we are excited to launch GlobalData’s Innovation Scorecard. This scorecard will allow clients to rank 3,500+ companies on their innovation activity, impact, and disruptive potential across geography, sector, and theme. The scorecard provides a data-driven framework to rank leading companies on the potential of their intellectual property (IP) portfolio. GlobalData’s Innovation Scorecard focuses not only on the activity of innovation in the organization but also on its impact and disruptive potential using the 3I framework: Intensity, Impact, and Ingenuity. The tool helps clients to identify the most innovative companies that are disruptive leaders and challengers and can create alpha for their portfolio using the insights driven by 19+ high-value KPIs. Download our report to find out more about this innovative tool. Key findings derived from this tool include:
  • Alphabet, Tencent, and Qualcomm are the top three innovative companies in the last 10 years
  • The scorecard finds Technology & Communications and Pharma & Healthcare as the two main sectors driving innovation
  • Loreal placed as ‘Disruptive Leader’ in the Consumer sector, while Revlon has been identified as a traditional laggard
  • Companies such as Etsy and H&M are challenging retail ‘Disruptive Leaders’ Amazon and Walmart
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena